Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — September 2019

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    BiotechPro
    wrote on sidst redigeret af
    #621

    o. I mellemtiden har
    Zealand Pharma modtaget en milepælsbetaling på omkring
    149 mio. kr., mens man har udstedt 4 mio. nye aktier til en storaktionær for en samlet værdi på omkring 560 mio. kr

    1 Reply Last reply
    0
    • B Offline
      B Offline
      BiotechPro
      wrote on sidst redigeret af
      #622

      Vi vurderer, at disse begivenheder reducerer den kommercielle risiko
      markant. Som følge heraf hæver vi vores anbefaling til Hold (Sælg), mens vi hæver vores kursmål til 168 kr. (145 kr.).

      1 Reply Last reply
      0
      • V Offline
        V Offline
        Vitus
        wrote on sidst redigeret af
        #623

        Zealand har deres egen chat.....

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #624

          this Dara SC trial was completed in august. Will be interesting to see the result; will premedication with corticosteroids be required or not https://clinicaltrials.gov/ct2/history/NCT03320707?A=5&B=6&C=merged#StudyPageTop

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #625

            Indeed. Will save time.

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #626

              Har lige ramt Regstrup. Hvad har I dog gjort ved kursen i dag?

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #627

                I mellemtiden kan vi f.eks. kigge nærmere på denne case fra den gode Sukkeralf: http://www.proinvestor.com/debat/76969

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #628

                  @Bulder certainly. and besides that dexamethason is not a nice drug to have to take... But what I still always have in the back of my head is that corticosteroids were probably the reason for the potential safety issue in the lung cancer study

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #629

                    Yes, but we are only talking of premedication. This doesn't rule out steroids (dex, pred) as treatment.

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #630

                      Just a moment...

                      favicon

                      (www.firstwordpharma.com)

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #631

                        Så bliver det interessant om det går som i Japan, hvor HPV-vaccinationsraten er nærmest lig nul, efter at staten har trukket anbefaling af HPV-vaccine tilbage. https://ijme.in/articles/lessons-learnt-in-japan-from-adverse-reactions-to-the-hpv-vaccine-a-medical-ethics-perspective/?galley=html

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #632

                          Men det kan så være, at det vil fremme behandlingsregimerne (såsom TV), da flere må formodes at få lmhk i udbrud. https://www.asianscientist.com/2019/02/in-the-lab/hpv-vaccination-cervical-cancer-japan/

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #633

                            Yderst beklageligt hvis f.eks. TV får succes på den sørgelige baggrund.

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #634

                              https://www.cancer.dk/hpv-vaccine/hpv-vaccine-og-bivirkninger/

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #635

                                Evaluating Control Regimens in Phase III Clinical Trials for Early-Relapsed Multiple Myeloma
                                Sagar Lonial - https://www.targetedonc.com/videos/evaluating-control-regimens-in-phase-iii-clinical-trials-for-earlyrelapsed-multiple-myeloma

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #636

                                  "In our current practice we try and use a daratumumab based backbone and then decide what is the best partner for daratumumab "

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #637

                                    Det har været diskuteret før: Er det bedst at spare lidt på krudtet til senere, eller skal man fyre det bedste af så tidligt som muligt i behandlingsforløbet. Brian Durie er ikke i tvivl:
                                    https://www.myeloma.org/videos/is-it-good-idea-save-your-best-treatment-for-later

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #638

                                      Kort om GSK's BCMA ADC: https://www.myeloma.org/videos/gsk-2857916-also-known-belantamab-mafodotin

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #639

                                        Stoffet hedder belantamab (som han ikke kan udtale) mafodotin, og han mener det vil komme til at hedde "bela" ligesom "dara". Jeg vil dog tro at det snarere bliver til belaM.

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          peter12
                                          wrote on sidst redigeret af
                                          #640

                                          Han har det lidt svært med navne, f.eks det velkendte Gaia forsøg 😉 https://www.myeloma.org/videos/daratumab-being-used-frontline-setting-myeloma-patients

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger